Lilly To Take $495M Charge To Settle Zyprexa Suits
Eli Lilly & Co. said Thursday that it will record charge of $495 million in the fourth quarter to settle product-liability claims related to the schizophrenia drug Zyprexa....To view the full article, register now.
Already a subscriber? Click here to view full article